Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn

Status Recruiting

Clinical Trial Summary

We hypothesized that adopting a lower rather than a higher threshold for phototherapy discontinuation will be associated with reduced rates of rebound hyperbilirubinemia in term and late preterm neonates with hemolytic disease of newborn.

Objectives: The investigators aimed to compare the safety of implementing low-threshold, compared to high- threshold, of TSB for phototherapy interruption in term and late preterm neonates with hemolytic disease of newborn.

Clinical Trial Description

Neonates in high-threshold group phototherapy will be ceased if TSB level is 50-100 µmol/L below the appropriate 2004 AAP phototherapy threshold, whereas neonates in the low-threshold group phototherapy will be stopped if TSB reached ˃100 µmol/L below the AAP threshold.

Phototherapy will be commenced for neonates in both groups according to AAP guidelines.Neonates will be treated with intensified overhead blue LEDs phototherapy if they have a TSB level at or above phototherapy threshold. Neonates will be started on intensified 360◦ LED phototherapy if they have TSB level within 50µmol/L below the exchange threshold. The administration of IVIG is indicated in infants with isoimmune hemolytic disease if TSB lies within 34 to 51 micromol/L of the threshold for exchange transfusion and not responding to initial intensified phototherapy.Infants with a TSB concentration above the thresholds for exchange should have immediate intensified 360◦ LED phototherapy, and preparation for exchange transfusion will be started.Infants showed clinical signs of acute bilirubin encephalopathy will have an immediate exchange transfusion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04218318
Study type	Interventional
Source	Ministry of Health, Saudi Arabia
Contact	Fatimah S Alhazmi, MD
Phone	00 966 54 0564141
Email	f.alhazmi@hotmail.com
Status	Recruiting
Phase	N/A
Start date	October 1, 2019
Completion date	November 15, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06186349` - The Effect and Mechanism of Gene Variation on Neonatal Hyperbilirubinemia
Recruiting	`NCT04369313` - Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers	N/A
Not yet recruiting	`NCT04585828` - Comparison of Double Pad Fiber Optic Device Versus Conventional Phototherapy	N/A
Completed	`NCT02927093` - Clinical and Developmental Outcomes of Babies Who Became Yellow in the First Month of Life	N/A
Unknown status	`NCT01340339` - Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants	Phase 4
Completed	`NCT02033096` - Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)
Active, not recruiting	`NCT02602301` - The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels	Phase 4
Completed	`NCT00801619` - Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia	N/A
Active, not recruiting	`NCT05343403` - Parental Participation on the Neonatal Ward - the neoPARTNER Study
Completed	`NCT03880591` - Neonatal Hyperbilirubinaemia in the Democratic Republic of Congo
Completed	`NCT01599611` - Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study	N/A
Recruiting	`NCT06399146` - Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana	N/A
Completed	`NCT06018012` - MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates
Completed	`NCT03536078` - Home Phototherapy for Term Newborns With Icterus	N/A
Withdrawn	`NCT00917007` - Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Recruiting	`NCT00154960` - Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.	N/A
Recruiting	`NCT02594904` - Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency	Phase 4
Completed	`NCT01746511` - Glycerin Suppositories to Reduce Jaundice in Premature Infants	N/A
Completed	`NCT01470820` - Dose-response Relationship of Phototherapy for Hyperbilirubinaemia Using Diodes: is There a "Saturation Point"	N/A
Completed	`NCT02361788` - Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)